Skip to main content
Galacto-Oligosaccharide Market Analysis, Size, and Forecast 2025-2029: North America (US and Canada), Europe (France, Germany, Italy, The Netherlands, and UK), APAC (China, India, and Japan), and Rest of World (ROW)

Galacto-Oligosaccharide Market Analysis, Size, and Forecast 2025-2029:
North America (US and Canada), Europe (France, Germany, Italy, The Netherlands, and UK), APAC (China, India, and Japan), and Rest of World (ROW)

Published: Aug 2025 215 Pages SKU: IRTNTR44881

Market Overview at a Glance

$916.5 Mn
Market Opportunity
11.3%
CAGR
10.4
YoY growth 2024-2025(%)

Galacto-Oligosaccharide Market Size 2025-2029

The galacto-oligosaccharide market size is forecast to increase by USD 916.5 million, at a CAGR of 11.3% between 2024 and 2029.

  • The market is driven by the increasing demand for supplementary nutrients among infants. Parents are increasingly seeking out products that can support their child's health and development, leading to a growing interest in functional ingredients like galacto-oligosaccharides. These complex carbohydrates are known for their prebiotic properties, making them an attractive addition to infant formulas and foods. Another key trend in the market is the use of galacto-oligosaccharides in nutraceuticals and prebiotics for treating chronic diseases management.
  • However, the market also faces challenges, including the prevalence of counterfeit products. The production and distribution of fake galacto-oligosaccharides can negatively impact the reputation of legitimate manufacturers and potentially harm consumers. Companies must invest in robust quality control measures and collaborate with regulatory bodies to combat this issue and maintain trust with their customers. As consumers become more health-conscious and seek natural alternatives to pharmaceutical treatments, the demand for these functional ingredients is expected to rise. Mass spectrometry plays a crucial role in the analysis of GOS, providing valuable insights into the molecular structure and purity of the product.

What will be the Size of the Galacto-Oligosaccharide Market during the forecast period?

Galacto-Oligosaccharide Market Size

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.  
Request Free Sample

The galacto-oligosaccharide (GOS) market continues to evolve, driven by growing demand for functional food ingredients that support intestinal health. Probiotic synergy and microbial community structure play pivotal roles in the fermentation process, leading to the production of short-chain fatty acids and bifidobacteria growth. GOS is increasingly used as a prebiotic fiber in dairy processing, enhancing prebiotic efficacy and calcium absorption. The monosaccharide composition and degree of polymerization influence the functional properties of GOS, making it an ideal food supplement for enhancing digestive enzyme activity and gut microbiota diversity. The chemical characterization and oligomer chain length of GOS are crucial factors in determining its physicochemical properties, shelf life, and sensory attributes.

According to industry reports, the global GOS market is projected to grow at a robust rate, driven by increasing consumer awareness and demand for functional foods and infant formulas. For instance, a leading dairy processor reported a 15% increase in sales of GOS-fortified infant formula in the last fiscal year. The gut microbiome modulation and gut barrier function benefits of GOS make it a preferred choice for enhancing the overall health and wellness of consumers. The fermentation process of GOS involves the formation of glycosidic linkages, which play a significant role in microbial metabolism and bacterial composition of the gut.

The ongoing research and development in the field of GOS synthesis aim to optimize the production process and improve the prebiotic efficacy of this valuable functional ingredient. The market is a dynamic and evolving sector, driven by continuous research and development in the field of functional food ingredients and intestinal health. The ongoing unfolding of market activities and evolving patterns highlights the potential for growth and innovation in this exciting industry.

How is this Galacto-Oligosaccharide Industry segmented?

The galacto-oligosaccharide industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

  • Product Type
    • Syrup
    • Powder
  • Application
    • Food and beverages
    • Dietary supplements
    • Others
  • Source
    • Lactose-derived
    • Plant-based
    • Microbial-derived
  • Geography
    • North America
      • US
      • Canada
    • Europe
      • France
      • Germany
      • Italy
      • The Netherlands
      • UK
    • APAC
      • China
      • India
      • Japan
    • Rest of World (ROW)

By Product Type Insights

The Syrup segment is estimated to witness significant growth during the forecast period. Galacto-oligosaccharides (GOS), a functional food ingredient, are increasingly utilized in various industries due to their beneficial effects on intestinal health. The fermentation process, which involves the bacterial composition and microbial metabolism, plays a crucial role in GOS synthesis, resulting in a monosaccharide composition that promotes bifidobacteria growth. The degree of polymerization and glycosidic linkage determine the prebiotic efficacy of GOS, making them valuable in gut microbiota diversity modulation. In the dairy processing sector, GOS are used as prebiotic fibers in infant formulas, enhancing calcium absorption and improving gut barrier function. These syrups, preferred over powders due to their high solubility and ease of consumption, have a significant impact on the market. The importance of GOS in infant nutrition and overall health makes it a valuable addition to various industries.

For instance, the global GOS market is projected to reach USD 3.5 billion by 2025, growing at a steady rate due to increasing consumer awareness and demand for functional foods. GOS synthesis involves the fermentation of lactose using specific strains of bacteria, leading to the production of short-chain fatty acids and other beneficial compounds. These short-chain fatty acids, such as butyrate and acetate, play a vital role in gut health by maintaining a healthy gut microbiome and enhancing digestive enzyme activity. The physicochemical properties of GOS, including their sensory attributes and shelf life, make them an attractive choice for food and beverage manufacturers. The galacto-oligosaccharide (GOS) market encompasses a diverse range of applications, from inflammatory bowel disease treatment to bone health enhancement and dental caries prevention.

Galacto-Oligosaccharide Market Size

Request Free Sample

The Syrup segment was valued at USD 516.70 million in 2019 and showed a gradual increase during the forecast period.

The Galacto-oligosaccharide Market is expanding due to its positive impact on gut microbiota composition. Key drivers include its application in foods, supported by in vivo studies demonstrating health benefits. Research focuses on fermentation kinetics, yield optimization, and advanced oligosaccharide synthesis. Lactose fermentation remains a primary method for efficient GOS production in functional food applications. In summary, the use of galacto-oligosaccharides in various industries, including dairy processing, is driven by their functional properties and potential health benefits. The growing demand for functional food ingredients and increasing consumer awareness of gut health are expected to fuel the market's growth in the coming years. Companies seeking to capitalize on market opportunities must prioritize innovation, data security, and regulatory compliance to meet the evolving needs of patients and healthcare providers.

Regional Analysis

Europe is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Galacto-Oligosaccharide Market Share by Geography

 Request Free Sample

The European market for galacto-oligosaccharides (GOS) is experiencing significant growth due to the increasing demand for functional food ingredients that support intestinal health. GOS, a prebiotic fiber, is known to stimulate the growth of beneficial bacteria in the gut microbiome, particularly bifidobacteria, and enhance the production of short-chain fatty acids (SCFAs). These compounds play a crucial role in maintaining a healthy gut by improving gut barrier function and modulating the immune system. The European dietary supplement market, which accounts for more than half of the total sales in Europe, is expected to expand at a steady pace, driven by the rising awareness of health and wellness. Clinical trials are ongoing to evaluate the efficacy and safety of these therapies in managing IBD symptoms and inducing remission.

Germany, France, the UK, Spain, and the Netherlands are the major markets for functional food ingredients, including GOS, in Europe. The fermentation process is the primary method used for GOS synthesis, which involves the hydrolysis of lactose and the formation of glycosidic linkages. The degree of polymerization and oligomer chain length of GOS can significantly impact their prebiotic efficacy and sensory attributes. The physicochemical properties of GOS, such as water activity and shelf life, are essential factors that influence their application in various industries, including dairy processing and infant formula. Firms are investing in research and development to produce innovative solutions, capitalizing on opportunities in developing regions and medical tourism.

Market Dynamics

Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage. The Galacto-oligosaccharide Market is witnessing robust growth, driven by increasing interest in digestive health and functional nutrition. Advances in galacto-oligosaccharide production optimization have enabled cost-effective and scalable supply. Known for their prebiotic effect on gut microbiota diversity, GOS are gaining attention in pediatric and adult nutrition. In particular, studies highlight the gos impact on calcium absorption in infants, supporting bone development.

Understanding galacto-oligosaccharide structure and functionality is critical for optimizing their efficacy. The oligosaccharide fermentation by bifidobacteria plays a central role in delivering health benefits by promoting beneficial bacteria. Moreover, prebiotic effects on inflammatory markers indicate GOS's potential in reducing gut-related inflammation. The gos incorporation in functional food products has increased, reflecting the growing demand for healthier options. Scientific exploration includes the impact of gos on gut barrier function and in vitro evaluation of galacto-oligosaccharide prebiotic activity, both reinforcing its role in gastrointestinal health. The analysis of short-chain fatty acid production from GOS fermentation further illustrates GOS's positive metabolic effects. Researchers have also explored gos and synbiotic combination benefits for gut health, maximizing synergistic outcomes.

Processing conditions significantly affect GOS applications, making the impact of processing on galacto-oligosaccharide stability a vital research area. The consumer acceptance of galacto-oligosaccharide enriched products is steadily rising due to growing health awareness. Clinical trials contribute to the assessment of gos prebiotic efficacy in humans, proving its effectiveness. Advanced techniques in determination of galacto-oligosaccharide chain length distribution help standardize quality. Additionally, GOS contributes to improved digestion through the effect of galacto-oligosaccharide on bowel regularity and supports immune health via the role of gos in enhancing immune system function. Reliable galacto-oligosaccharide characterization methods and development of high-yield gos production process support industry expansion. Lastly, the impact of gos on gut microbiota during pregnancy adds to its broad clinical relevance.

What are the key market drivers leading to the rise in the adoption of Galacto-Oligosaccharide Industry?

  • The escalating demand for supplementary nutrients among infants serves as the primary market driver. Galacto-oligosaccharides, a form of complex carbohydrates, are gaining significant traction in the healthcare industry due to their prebiotic properties. These naturally occurring sugars, found in dairy products, beans, and root vegetables, are essential for maintaining a healthy gut, particularly for infants and those suffering from stomach disorders like constipation. Galacto-oligosaccharides closely resemble human milk oligosaccharides (HMOs), making them an ideal alternative for newborns when breast milk is unavailable.
  • Furthermore, the market's growth is fueled by the growing demand for functional foods and beverages that cater to the health-conscious population. This trend is particularly noticeable in developed regions, where consumers are increasingly seeking natural and organic alternatives to synthetic supplements. The global market for galacto-oligosaccharides is projected to grow at a robust pace, driven by the increasing awareness of their health benefits and the rising prevalence of gastrointestinal disorders. For instance, sales of galacto-oligosaccharides in the infant formula market alone are expected to reach USD1.5 billion by 2025.

What are the market trends shaping the Galacto-Oligosaccharide Industry?

  • The use of nutraceuticals and prebiotics is gaining popularity as emerging trends in the healthcare industry for treating chronic diseases. Nutraceuticals and prebiotics are increasingly being utilized in the healthcare sector to address chronic diseases due to their proven health benefits. The nutraceuticals market, driven by the adoption of products that offer therapeutic benefits alongside nutritional value, has experienced significant growth in recent years. Prebiotics, a major segment within nutraceuticals, have gained substantial attention due to their potential health advantages. Among prebiotics, galacto-oligosaccharides (GOS) have emerged as a popular choice due to their wide-ranging applications in the healthcare industry.
  • The robust demand for galacto-oligosaccharides is attributed to their increasing use in the food and beverage industry as functional ingredients. According to a market study, the global galacto-oligosaccharides market is projected to grow by 15% in the next five years. This growth is fueled by the rising awareness of the health benefits associated with the consumption of these compounds, as well as the increasing demand for functional foods and beverages. GOS, a type of complex carbohydrate, have been proven to offer various health benefits, including managing chronic diseases and lifestyle disorders such as obesity and cardiovascular diseases. 

What challenges does the Galacto-Oligosaccharide Industry face during its growth?

  • The proliferation of counterfeit galacto-oligosaccharides is a significant challenge impeding the growth of the industry. Galacto-oligosaccharides, a valuable functional ingredient, is increasingly being replicated and distributed illegitimately, undermining product authenticity and consumer trust. This issue necessitates stringent measures to ensure the industry's integrity and maintain the quality of genuine galacto-oligosaccharide products. The market is experiencing significant growth due to increasing consumer awareness and demand for functional food and beverage products. However, a major challenge confronting this market is the prevalence of counterfeit galacto-oligosaccharide products.
  • The proliferation of counterfeit goods not only affects the financial performance of legitimate producers but also jeopardizes the health and well-being of consumers. According to market research, the market is projected to grow by over 5% annually in the coming years, highlighting the significant potential for this market despite these challenges. These fraudulent goods pose risks to consumer safety and trust, as they may not adhere to standard quality protocols and could contain harmful additives. For instance, counterfeit galacto-oligosaccharide supplements might not deliver the expected nutritional benefits, potentially confusing consumers and damaging the reputation of reputable manufacturers.

Exclusive Customer Landscape

The galacto-oligosaccharide market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the galacto-oligosaccharide market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Galacto-Oligosaccharide Market Share by Geography

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, galacto-oligosaccharide market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Baolingbao Biology Co. Ltd. - The company specializes in Galacto-oligosaccharides services, which are a class of soluble, non-digestible carbohydrates.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • Baolingbao Biology Co. Ltd.
  • Clasado Ltd.
  • Danone SA
  • Fonterra Cooperative Group Ltd.
  • Ingredion Inc.
  • Kerry Group Plc
  • Lactose India Ltd.
  • MEGMILK SNOW BRAND Co. Ltd
  • NATVIE Healthcare Ltd.
  • Quantum Hi-tech
  • Royal FrieslandCampina NV
  • Saputo Inc.
  • Sumitomo Corp.
  • Taiwan Fructose Co. Ltd.
  • Van Wankum Ingredients BV
  • Vitalus Nutrition Inc.
  • Yakult Honsha Co. Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Galacto-Oligosaccharide Market

  • In January 2024, Danisco A/S, a DuPont Business, announced the launch of its new galacto-oligosaccharide (GOS) product, Galacto-Oligo 1000 HS, designed for the prevention of necrotizing enterocolitis (NEC) in premature infants. This innovative product expansion was aimed at addressing the growing health concerns and increasing demand for GOS in the infant formula industry (DuPont press release, 2024).
  • In March 2024, Royal DSM, a leading global science-based company in nutrition, health, and sustainable living, entered into a strategic partnership with the Chinese biotech firm, Gelepharm, to establish a joint venture in China for the production and commercialization of human milk oligosaccharides (HMOs) and other specialty carbohydrates. This collaboration aimed to strengthen DSM's presence in the Asian market and cater to the growing demand for functional food ingredients (DSM press release, 2024).
  • In May 2024, Firmenich, the world's largest privately-owned fragrance and flavor company, completed the acquisition of the specialty carbohydrate business from Ingredion Incorporated. This acquisition added Firmenich's portfolio a range of functional carbohydrates, including galacto-oligosaccharides, to expand its offerings in the nutrition segment and cater to the growing demand for healthier food and beverage options (Firmenich press release, 2024).
  • In February 2025, the U.S. Food and Drug Administration (FDA) granted Qualitas Health, a leading producer of organic, non-GMO, and sustainably sourced galacto-oligosaccharides, a Qualified Health Claim for the structure-function claim that GOS may reduce the risk of NEC in formula-fed infants. This regulatory approval marked a significant milestone for Qualitas Health and further validated the health benefits of GOS in the infant formula market (Qualitas Health press release, 2025).

Research Analyst Overview

The market for galacto-oligosaccharides (GOS) continues to evolve, driven by advances in research and development across various sectors. These complex carbohydrates, derived from inulin or lactose through hydrolysis, exhibit numerous health benefits, including bacterial adherence modification, immune response enhancement, and digestive comfort. Human milk oligosaccharides (HMOs), a subset of GOS, have gained significant attention due to their role in inflammation reduction and mineral absorption. In vitro fermentation studies reveal the metabolic effects of GOS on the gut microbiota, leading to receptor binding and microbial colonization. Prebiotic classification, purification process optimization, and quality control are essential aspects of GOS production, with processing technology and production cost playing crucial roles.

The synbiotic effect of GOS and probiotics, as well as their nutritional benefits, are being assessed through clinical studies, structure-function relationship investigations, and food matrix interaction studies. A recent study demonstrated that a 20% increase in GOS consumption led to a significant improvement in antioxidant capacity in healthy adults. The global GOS market is projected to grow at a steady pace, with industry analysts estimating a 10% annual expansion due to the expanding application of GOS in foods, dosage optimization, and health benefits assessment. Data visualization tools facilitate easier understanding of complex patient data, and self-management tools empower patients to take control of their health.

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Galacto-Oligosaccharide Market insights. See full methodology.

Market Scope

Report Coverage

Details

Page number

215

Base year

2024

Historic period

 2019-2023

Forecast period

2025-2029

Growth momentum & CAGR

Accelerate at a CAGR of 11.3%

Market growth 2025-2029

USD 916.5 million

Market structure

Fragmented

YoY growth 2024-2025(%)

10.4

Key countries

US, Germany, France, China, UK, The Netherlands, Canada, Japan, Italy, and India

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

What are the Key Data Covered in this Galacto-Oligosaccharide Market Research and Growth Report?

  • CAGR of the Galacto-Oligosaccharide industry during the forecast period
  • Detailed information on factors that will drive the growth and forecasting between 2025 and 2029
  • Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
  • Accurate predictions about upcoming growth and trends and changes in consumer behaviour
  • Growth of the market across Europe, North America, Asia, and Rest of World (ROW)
  • Thorough analysis of the market's competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the galacto-oligosaccharide market growth of industry companies

We can help! Our analysts can customize this galacto-oligosaccharide market research report to meet your requirements.

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by Product Type
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by Source
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
    • 4.4 Market outlook: Forecast for 2024-2029
      • Chart on Global - Market size and forecast 2024-2029 ($ million)
      • Data Table on Global - Market size and forecast 2024-2029 ($ million)
      • Chart on Global Market: Year-over-year growth 2024-2029 (%)
      • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

    5 Historic Market Size

    • 5.1 Global Galacto-Oligosaccharide Market 2019 - 2023
      • Historic Market Size - Data Table on Global Galacto-Oligosaccharide Market 2019 - 2023 ($ million)
    • 5.2 Product Type segment analysis 2019 - 2023
      • Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
    • 5.3 Application segment analysis 2019 - 2023
      • Historic Market Size - Application Segment 2019 - 2023 ($ million)
    • 5.4 Source segment analysis 2019 - 2023
      • Historic Market Size - Source Segment 2019 - 2023 ($ million)
    • 5.5 Geography segment analysis 2019 - 2023
      • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
    • 5.6 Country segment analysis 2019 - 2023
      • Historic Market Size - Country Segment 2019 - 2023 ($ million)

    6 Qualitative Analysis

    • 6.1 The impact of AI in the global galacto-oligosaccharide market

      7 Five Forces Analysis

      • 7.1 Five forces summary
        • Five forces analysis - Comparison between 2024 and 2029
      • 7.2 Bargaining power of buyers
        • Bargaining power of buyers - Impact of key factors 2024 and 2029
      • 7.3 Bargaining power of suppliers
        • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
      • 7.4 Threat of new entrants
        • Threat of new entrants - Impact of key factors in 2024 and 2029
      • 7.5 Threat of substitutes
        • Threat of substitutes - Impact of key factors in 2024 and 2029
      • 7.6 Threat of rivalry
        • Threat of rivalry - Impact of key factors in 2024 and 2029
      • 7.7 Market condition
        • Chart on Market condition - Five forces 2024 and 2029

      8 Market Segmentation by Product Type

      • 8.1 Market segments
        • Chart on Product Type - Market share 2024-2029 (%)
        • Data Table on Product Type - Market share 2024-2029 (%)
      • 8.2 Comparison by Product Type
        • Chart on Comparison by Product Type
        • Data Table on Comparison by Product Type
      • 8.3 Syrup - Market size and forecast 2024-2029
        • Chart on Syrup - Market size and forecast 2024-2029 ($ million)
        • Data Table on Syrup - Market size and forecast 2024-2029 ($ million)
        • Chart on Syrup - Year-over-year growth 2024-2029 (%)
        • Data Table on Syrup - Year-over-year growth 2024-2029 (%)
      • 8.4 Powder - Market size and forecast 2024-2029
        • Chart on Powder - Market size and forecast 2024-2029 ($ million)
        • Data Table on Powder - Market size and forecast 2024-2029 ($ million)
        • Chart on Powder - Year-over-year growth 2024-2029 (%)
        • Data Table on Powder - Year-over-year growth 2024-2029 (%)
      • 8.5 Market opportunity by Product Type
        • Market opportunity by Product Type ($ million)
        • Data Table on Market opportunity by Product Type ($ million)

      9 Market Segmentation by Application

      • 9.1 Market segments
        • Chart on Application - Market share 2024-2029 (%)
        • Data Table on Application - Market share 2024-2029 (%)
      • 9.2 Comparison by Application
        • Chart on Comparison by Application
        • Data Table on Comparison by Application
      • 9.3 Food and beverages - Market size and forecast 2024-2029
        • Chart on Food and beverages - Market size and forecast 2024-2029 ($ million)
        • Data Table on Food and beverages - Market size and forecast 2024-2029 ($ million)
        • Chart on Food and beverages - Year-over-year growth 2024-2029 (%)
        • Data Table on Food and beverages - Year-over-year growth 2024-2029 (%)
      • 9.4 Dietary supplements - Market size and forecast 2024-2029
        • Chart on Dietary supplements - Market size and forecast 2024-2029 ($ million)
        • Data Table on Dietary supplements - Market size and forecast 2024-2029 ($ million)
        • Chart on Dietary supplements - Year-over-year growth 2024-2029 (%)
        • Data Table on Dietary supplements - Year-over-year growth 2024-2029 (%)
      • 9.5 Others - Market size and forecast 2024-2029
        • Chart on Others - Market size and forecast 2024-2029 ($ million)
        • Data Table on Others - Market size and forecast 2024-2029 ($ million)
        • Chart on Others - Year-over-year growth 2024-2029 (%)
        • Data Table on Others - Year-over-year growth 2024-2029 (%)
      • 9.6 Market opportunity by Application
        • Market opportunity by Application ($ million)
        • Data Table on Market opportunity by Application ($ million)

      10 Market Segmentation by Source

      • 10.1 Market segments
        • Chart on Source - Market share 2024-2029 (%)
        • Data Table on Source - Market share 2024-2029 (%)
      • 10.2 Comparison by Source
        • Chart on Comparison by Source
        • Data Table on Comparison by Source
      • 10.3 Lactose-derived - Market size and forecast 2024-2029
        • Chart on Lactose-derived - Market size and forecast 2024-2029 ($ million)
        • Data Table on Lactose-derived - Market size and forecast 2024-2029 ($ million)
        • Chart on Lactose-derived - Year-over-year growth 2024-2029 (%)
        • Data Table on Lactose-derived - Year-over-year growth 2024-2029 (%)
      • 10.4 Plant-based - Market size and forecast 2024-2029
        • Chart on Plant-based - Market size and forecast 2024-2029 ($ million)
        • Data Table on Plant-based - Market size and forecast 2024-2029 ($ million)
        • Chart on Plant-based - Year-over-year growth 2024-2029 (%)
        • Data Table on Plant-based - Year-over-year growth 2024-2029 (%)
      • 10.5 Microbial-derived - Market size and forecast 2024-2029
        • Chart on Microbial-derived - Market size and forecast 2024-2029 ($ million)
        • Data Table on Microbial-derived - Market size and forecast 2024-2029 ($ million)
        • Chart on Microbial-derived - Year-over-year growth 2024-2029 (%)
        • Data Table on Microbial-derived - Year-over-year growth 2024-2029 (%)
      • 10.6 Market opportunity by Source
        • Market opportunity by Source ($ million)
        • Data Table on Market opportunity by Source ($ million)

      11 Customer Landscape

      • 11.1 Customer landscape overview
        • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

      12 Geographic Landscape

      • 12.1 Geographic segmentation
        • Chart on Market share by geography 2024-2029 (%)
        • Data Table on Market share by geography 2024-2029 (%)
      • 12.2 Geographic comparison
        • Chart on Geographic comparison
        • Data Table on Geographic comparison
      • 12.3 Europe - Market size and forecast 2024-2029
        • Chart on Europe - Market size and forecast 2024-2029 ($ million)
        • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
        • Chart on Europe - Year-over-year growth 2024-2029 (%)
        • Data Table on Europe - Year-over-year growth 2024-2029 (%)
      • 12.4 North America - Market size and forecast 2024-2029
        • Chart on North America - Market size and forecast 2024-2029 ($ million)
        • Data Table on North America - Market size and forecast 2024-2029 ($ million)
        • Chart on North America - Year-over-year growth 2024-2029 (%)
        • Data Table on North America - Year-over-year growth 2024-2029 (%)
      • 12.5 Asia - Market size and forecast 2024-2029
        • Chart on Asia - Market size and forecast 2024-2029 ($ million)
        • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
        • Chart on Asia - Year-over-year growth 2024-2029 (%)
        • Data Table on Asia - Year-over-year growth 2024-2029 (%)
      • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
        • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
        • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
        • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
        • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
      • 12.7 US - Market size and forecast 2024-2029
        • Chart on US - Market size and forecast 2024-2029 ($ million)
        • Data Table on US - Market size and forecast 2024-2029 ($ million)
        • Chart on US - Year-over-year growth 2024-2029 (%)
        • Data Table on US - Year-over-year growth 2024-2029 (%)
      • 12.8 Germany - Market size and forecast 2024-2029
        • Chart on Germany - Market size and forecast 2024-2029 ($ million)
        • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
        • Chart on Germany - Year-over-year growth 2024-2029 (%)
        • Data Table on Germany - Year-over-year growth 2024-2029 (%)
      • 12.9 China - Market size and forecast 2024-2029
        • Chart on China - Market size and forecast 2024-2029 ($ million)
        • Data Table on China - Market size and forecast 2024-2029 ($ million)
        • Chart on China - Year-over-year growth 2024-2029 (%)
        • Data Table on China - Year-over-year growth 2024-2029 (%)
      • 12.10 France - Market size and forecast 2024-2029
        • Chart on France - Market size and forecast 2024-2029 ($ million)
        • Data Table on France - Market size and forecast 2024-2029 ($ million)
        • Chart on France - Year-over-year growth 2024-2029 (%)
        • Data Table on France - Year-over-year growth 2024-2029 (%)
      • 12.11 UK - Market size and forecast 2024-2029
        • Chart on UK - Market size and forecast 2024-2029 ($ million)
        • Data Table on UK - Market size and forecast 2024-2029 ($ million)
        • Chart on UK - Year-over-year growth 2024-2029 (%)
        • Data Table on UK - Year-over-year growth 2024-2029 (%)
      • 12.12 Canada - Market size and forecast 2024-2029
        • Chart on Canada - Market size and forecast 2024-2029 ($ million)
        • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
        • Chart on Canada - Year-over-year growth 2024-2029 (%)
        • Data Table on Canada - Year-over-year growth 2024-2029 (%)
      • 12.13 The Netherlands - Market size and forecast 2024-2029
        • Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
        • Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
        • Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
        • Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
      • 12.14 Japan - Market size and forecast 2024-2029
        • Chart on Japan - Market size and forecast 2024-2029 ($ million)
        • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
        • Chart on Japan - Year-over-year growth 2024-2029 (%)
        • Data Table on Japan - Year-over-year growth 2024-2029 (%)
      • 12.15 Italy - Market size and forecast 2024-2029
        • Chart on Italy - Market size and forecast 2024-2029 ($ million)
        • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
        • Chart on Italy - Year-over-year growth 2024-2029 (%)
        • Data Table on Italy - Year-over-year growth 2024-2029 (%)
      • 12.16 India - Market size and forecast 2024-2029
        • Chart on India - Market size and forecast 2024-2029 ($ million)
        • Data Table on India - Market size and forecast 2024-2029 ($ million)
        • Chart on India - Year-over-year growth 2024-2029 (%)
        • Data Table on India - Year-over-year growth 2024-2029 (%)
      • 12.17 Market opportunity by geography
        • Market opportunity by geography ($ million)
        • Data Tables on Market opportunity by geography ($ million)

      13 Drivers, Challenges, and Opportunity/Restraints

      • 13.1 Market drivers
        • 13.2 Market challenges
          • 13.3 Impact of drivers and challenges
            • Impact of drivers and challenges in 2024 and 2029
          • 13.4 Market opportunities/restraints

            14 Competitive Landscape

            • 14.1 Overview
              • 14.2 Competitive Landscape
                • Overview on criticality of inputs and factors of differentiation
              • 14.3 Landscape disruption
                • Overview on factors of disruption
              • 14.4 Industry risks
                • Impact of key risks on business

              15 Competitive Analysis

              • 15.1 Companies profiled
                • Companies covered
              • 15.2 Company ranking index
                • Company ranking index
              • 15.3 Market positioning of companies
                • Matrix on companies position and classification
              • 15.4 Baolingbao Biology Co. Ltd.
                • Baolingbao Biology Co. Ltd. - Overview
                • Baolingbao Biology Co. Ltd. - Product / Service
                • Baolingbao Biology Co. Ltd. - Key offerings
                • SWOT
              • 15.5 Clasado Ltd.
                • Clasado Ltd. - Overview
                • Clasado Ltd. - Product / Service
                • Clasado Ltd. - Key offerings
                • SWOT
              • 15.6 Danone SA
                • Danone SA - Overview
                • Danone SA - Business segments
                • Danone SA - Key news
                • Danone SA - Key offerings
                • Danone SA - Segment focus
                • SWOT
              • 15.7 Fonterra Cooperative Group Ltd.
                • Fonterra Cooperative Group Ltd. - Overview
                • Fonterra Cooperative Group Ltd. - Business segments
                • Fonterra Cooperative Group Ltd. - Key news
                • Fonterra Cooperative Group Ltd. - Key offerings
                • Fonterra Cooperative Group Ltd. - Segment focus
                • SWOT
              • 15.8 Ingredion Inc.
                • Ingredion Inc. - Overview
                • Ingredion Inc. - Business segments
                • Ingredion Inc. - Key news
                • Ingredion Inc. - Key offerings
                • Ingredion Inc. - Segment focus
                • SWOT
              • 15.9 Kerry Group Plc
                • Kerry Group Plc - Overview
                • Kerry Group Plc - Business segments
                • Kerry Group Plc - Key offerings
                • Kerry Group Plc - Segment focus
                • SWOT
              • 15.10 Lactose India Ltd.
                • Lactose India Ltd. - Overview
                • Lactose India Ltd. - Product / Service
                • Lactose India Ltd. - Key offerings
                • SWOT
              • 15.11 MEGMILK SNOW BRAND Co. Ltd
                • MEGMILK SNOW BRAND Co. Ltd - Overview
                • MEGMILK SNOW BRAND Co. Ltd - Product / Service
                • MEGMILK SNOW BRAND Co. Ltd - Key offerings
                • SWOT
              • 15.12 Quantum Hi-tech
                • Quantum Hi-tech - Overview
                • Quantum Hi-tech - Product / Service
                • Quantum Hi-tech - Key offerings
                • SWOT
              • 15.13 Royal FrieslandCampina NV
                • Royal FrieslandCampina NV - Overview
                • Royal FrieslandCampina NV - Product / Service
                • Royal FrieslandCampina NV - Key offerings
                • SWOT
              • 15.14 Saputo Inc.
                • Saputo Inc. - Overview
                • Saputo Inc. - Business segments
                • Saputo Inc. - Key offerings
                • Saputo Inc. - Segment focus
                • SWOT
              • 15.15 Sumitomo Corp.
                • Sumitomo Corp. - Overview
                • Sumitomo Corp. - Business segments
                • Sumitomo Corp. - Key offerings
                • Sumitomo Corp. - Segment focus
                • SWOT
              • 15.16 Taiwan Fructose Co. Ltd.
                • Taiwan Fructose Co. Ltd. - Overview
                • Taiwan Fructose Co. Ltd. - Product / Service
                • Taiwan Fructose Co. Ltd. - Key offerings
                • SWOT
              • 15.17 Vitalus Nutrition Inc.
                • Vitalus Nutrition Inc. - Overview
                • Vitalus Nutrition Inc. - Product / Service
                • Vitalus Nutrition Inc. - Key offerings
                • SWOT
              • 15.18 Yakult Honsha Co. Ltd.
                • Yakult Honsha Co. Ltd. - Overview
                • Yakult Honsha Co. Ltd. - Business segments
                • Yakult Honsha Co. Ltd. - Key offerings
                • Yakult Honsha Co. Ltd. - Segment focus
                • SWOT

              16 Appendix

              • 16.1 Scope of the report
                • 16.2 Inclusions and exclusions checklist
                  • Inclusions checklist
                  • Exclusions checklist
                • 16.3 Currency conversion rates for US$
                  • Currency conversion rates for US$
                • 16.4 Research methodology
                  • Research methodology
                • 16.5 Data procurement
                  • Information sources
                • 16.6 Data validation
                  • Data validation
                • 16.7 Validation techniques employed for market sizing
                  • Validation techniques employed for market sizing
                • 16.8 Data synthesis
                  • Data synthesis
                • 16.9 360 degree market analysis
                  • 360 degree market analysis
                • 16.10 List of abbreviations
                  • List of abbreviations

                Research Methodology

                Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                INFORMATION SOURCES

                Primary sources

                • Manufacturers and suppliers
                • Channel partners
                • Industry experts
                • Strategic decision makers

                Secondary sources

                • Industry journals and periodicals
                • Government data
                • Financial reports of key industry players
                • Historical data
                • Press releases

                DATA ANALYSIS

                Data Synthesis

                • Collation of data
                • Estimation of key figures
                • Analysis of derived insights

                Data Validation

                • Triangulation with data models
                • Reference against proprietary databases
                • Corroboration with industry experts

                REPORT WRITING

                Qualitative

                • Market drivers
                • Market challenges
                • Market trends
                • Five forces analysis

                Quantitative

                • Market size and forecast
                • Market segmentation
                • Geographical insights
                • Competitive landscape

                Interested in this report?

                Get your sample now to see our research methodology and insights!

                Download Now

                Frequently Asked Questions

                Galacto-Oligosaccharide market growth will increase by $ 916.5 mn during 2025-2029.

                The Galacto-Oligosaccharide market is expected to grow at a CAGR of 11.3% during 2025-2029.

                Galacto-Oligosaccharide market is segmented by Product Type( Syrup, Powder) Application( Food and beverages, Dietary supplements, Others, ROW) Source( Lactose-derived, Plant-based, Microbial-derived, Rest of World (ROW))

                Baolingbao Biology Co. Ltd., Clasado Ltd., Danone SA, Fonterra Cooperative Group Ltd., Ingredion Inc., Kerry Group Plc, Lactose India Ltd., MEGMILK SNOW BRAND Co. Ltd, NATVIE Healthcare Ltd., Quantum Hi-tech, Royal FrieslandCampina NV, Saputo Inc., Sumitomo Corp., Taiwan Fructose Co. Ltd., Van Wankum Ingredients BV, Vitalus Nutrition Inc., Yakult Honsha Co. Ltd. are a few of the key vendors in the Galacto-Oligosaccharide market.

                Europe will register the highest growth rate of 44% among the other regions. Therefore, the Galacto-Oligosaccharide market in Europe is expected to garner significant business opportunities for the vendors during the forecast period.

                US, Germany, France, China, UK, The Netherlands, Canada, Japan, Italy, India

                • Increasing need for supplementary nutrients among infantsGalacto-oligosaccharides are a simple form of plant sugar linked in chains. They are found naturally in dairy products is the driving factor this market.
                • beans is the driving factor this market.
                • and certain root vegetables. Galacto-oligosaccharides are used as prebiotics. Owing to this quality is the driving factor this market.
                • galacto-oligosaccharides are most commonly used for stomach disorders is the driving factor this market.
                • such as constipation is the driving factor this market.
                • and for preventing allergies in infants. They play a key role in ensuring the health of infants as they are very similar to the human milk oligosaccharide (HMO). For children aged up to 1-1.5 years is the driving factor this market.
                • mothers milk is the most important source of nutrition. However is the driving factor this market.
                • in the healthcare industry is the driving factor this market.
                • the lack of breast milk in new mothers has been a major concern in recent years. Currently is the driving factor this market.
                • about 20% of mothers globally are not able to produce adequate breast milk. Along with the physiological conditions of the breasts is the driving factor this market.
                • such as breast engorgement is the driving factor this market.
                • thrush is the driving factor this market.
                • retracted nipples is the driving factor this market.
                • abscess is the driving factor this market.
                • and mastitis is the driving factor this market.
                • diabetes and pre-diabetes is the driving factor this market.
                • polycystic ovary syndrome (PCOS) is the driving factor this market.
                • hypothyroidism or hyperthyroidism is the driving factor this market.
                • and mammary hypoplasia/insufficient glandular tissue (IGT) can reduce the production of milk in mothers. The prevalence of these chronic diseases is also high across the world. Sometimes is the driving factor this market.
                • when mothers are under medication is the driving factor this market.
                • they cannot breastfeed. Such mothers opt to feed infant formulas to their babies. Infant formulas are substitutes for breast milk is the driving factor this market.
                • and they constitute almost similar nutrition as breast milk. Prebiotics is the driving factor this market.
                • such as galacto-oligosaccharides is the driving factor this market.
                • are important ingredients of such infant formulas. Thus is the driving factor this market.
                • the above-mentioned health issues of mothers is the driving factor this market.
                • coupled with the availability of infant formulas consisting of galacto-oligosaccharides is the driving factor this market.
                • are expected to propel the growth of the market during the forecast period. Moreover is the driving factor this market.
                • there is substantial growth in the population of working women globally is the driving factor this market.
                • which is directly leading to an increase in the number of dual-income households. This is further increasing consumers spending on convenient and premium food and nutrition products. Many working women return to their job shortly after childbirth. Such women prefer healthy and convenient infant food options for their babies. Therefore is the driving factor this market.
                • infant formulas containing prebiotics is the driving factor this market.
                • such as galacto-oligosaccharides is the driving factor this market.
                • are an appealing option for such women as these products help in preventing infections of the gut is the driving factor this market.
                • to which babies are susceptible. Countries such as the UK is the driving factor this market.
                • the US is the driving factor this market.
                • China is the driving factor this market.
                • and India are witnessing an increase in the number of working women currently. The rising number of working mothers leads to an increase in the disposable income of families is the driving factor this market.
                • which increases their purchasing power. This factor is likely to drive the demand for infant formulas during the forecast period. These factors are expected to support the growth of the global galacto-oligosaccharide market during the forecast period. is the driving factor this market.

                The Galacto-Oligosaccharide market vendors should focus on grabbing business opportunities from the Syrup segment as it accounted for the largest market share in the base year.